The following clinical trials are being conducted:
S1400 - A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (LUNG-MAP)
Vector Oncology - prospective Observational Trial Evaluating Outcomes of FoundationOne® Directed Matched Targeted Therapy in Patients with Cancer of Unknown Primary (CUP).
Astellas TRUMPET Study: A Prospective Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (CRPC) in the United States.
Breast Cancer Collaborative Registry (BCCR) Study - a web-based data base / system developed by the University of Nebraska Medical Center (UNMC). http://bccr.unmc.edu/
Oral Anti-Cancer Therapy Research Study - The objective of this study is to assess whether or not patients taking oral anti-cancer therapies (oral antineoplasitc agents) i.e. chemotherapy, targeted biologic therapy, hormone therapy, etc. are adhering to their treatment regimen. If there appears to be a growing trend showing that patients are not adhering to their medication regimen, methods to improve adherence will be studied and implemented.
Protocol Title: Integrated Cancer Repository for Cancer Research (iCaRe2)
The iCaRe2 is a unique sociotechnical resource for the collection and management of cancer and health-related data.
The objectives of this project is to implement and maintain a comprehensive data and biospecimen bank known as the Integrated Cancer Repository for Cancer Research (iCaRe2). The data registry and biospecimen bank will provide core support services for multidisciplinary research on cancer and other chronic diseases carried out by internal and external research collaborators from different participating institutions/centers.